BioAge Labs Inc. (BIOA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases by targeting the biology of aging, is scheduled to participate in two major investor conferences next month, i.e., on Dec.3 and Dec.4.
The company CEO and co-founder, Kristen Fortney, will lead the presentation, followed by one-on-one meetings with investors.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com